The best enhancement (the highest CASP8, p53, and the lowest MMP9, IL-6, and VEGF) was shown in HCC + DAH, followed by HCC + SOR, and then the HCC + DAH + SOR group. This evidence concerns the gene CASP8 and hepatocellular carcinoma.